DAN vs PFE · rev $10.28B vs P/E 20, rev $62.58B
Dana Inc (DAN) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Dana Inc (DAN) is a auto parts company listed on US.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported DAN revenue for 2024-12-31 was $10.28B. Net income was -$49.0M. Revenue was down 2.6% from 2023-12-31 to 2024-12-31. DAN currently screens at market cap $2.52B.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
DAN currently screens at market cap $2.52B. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the DAN and PFE stock pages for the full models.
Not investment advice.